14
Participants
Start Date
April 5, 2018
Primary Completion Date
August 5, 2024
Study Completion Date
August 5, 2024
M281
Participants will receive once weekly intravenous (IV) infusions of M281
Liverpool Hospital, Sydney
Universitair Ziekenhuis Leuven, Leuven
Columbia University Medical Center, New York
University of Pittsburgh, Pittsburgh
Hosp. Univ. San Cecilio, Granada
Justus-Liebig-Universität Gießen, Kinderherzzentrum, Giessen
University of Cincinnati, Cincinnati
University of Texas Health Science Center, Houston
Dell Children's Medical Center of Central Texas, Austin
University of Utah, Salt Lake City
University of California San Francisco, San Francisco
Oregon Health and Science University, Portland
British Columbia Children's Hospital, Vancouver
Mount Sinai Hospital, Toronto
CHUM - Centre hospitalier universitaire de Montreal, Montreal
Leiden University Medical Center, Leiden
Karolinska Universitetssjukhuset Huddinge, Stockholm
Birmingham Children's Hospital, Birmingham
University College London Hospitals NHSFT, London
Janssen Research & Development, LLC
INDUSTRY